332 related articles for article (PubMed ID: 19546553)
1. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
Bouza C; López-Cuadrado T; Alcázar R; Saz-Parkinson Z; Amate JM
BMC Gastroenterol; 2009 May; 9():31. PubMed ID: 19432967
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yang B; Zan RY; Wang SY; Li XL; Wei ML; Guo WH; You X; Li J; Liao ZY
World J Surg Oncol; 2015 Mar; 13():96. PubMed ID: 25889181
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Lau WY; Leung TW; Yu SC; Ho SK
Ann Surg; 2003 Feb; 237(2):171-9. PubMed ID: 12560774
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?
Seinstra BA; van Delden OM; van Erpecum KJ; van Hillegersberg R; Mali WP; van den Bosch MA
Insights Imaging; 2010 Jul; 1(3):167-81. PubMed ID: 23100194
[TBL] [Abstract][Full Text] [Related]
6. Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
Hsieh C; Laguna A; Ikeda I; Maxwell AWP; Chapiro J; Nadolski G; Jiao Z; Bai HX
Radiology; 2023 Nov; 309(2):e222891. PubMed ID: 37934098
[TBL] [Abstract][Full Text] [Related]
7. Understanding Factors Governing Distribution Volume of Ethyl Cellulose-Ethanol to Optimize Ablative Therapy in the Liver.
Morhard R; Mueller JL; Tang Q; Nief C; Chelales E; Lam CT; Alvarez DA; Rubinstein M; Katz DF; Ramanujam N
IEEE Trans Biomed Eng; 2020 Aug; 67(8):2337-2348. PubMed ID: 31841399
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous ablation therapies of inoperable pancreatic cancer: a systematic review.
Ierardi AM; Lucchina N; Bacuzzi A; Marco de C; Bracchi E; Cocozza E; Dionigi G; Tsetis D; Floridi C; Carrafiello G
Ann Gastroenterol; 2015; 28(4):431-9. PubMed ID: 26424487
[TBL] [Abstract][Full Text] [Related]
9. Ablative strategies for recurrent hepatocellular carcinoma.
Wang L; Liu BX; Long HY
World J Hepatol; 2023 Apr; 15(4):515-524. PubMed ID: 37206650
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm.
Yang P; Li N
J Int Med Res; 2022 Jul; 50(7):3000605221111281. PubMed ID: 35861264
[TBL] [Abstract][Full Text] [Related]
11.
Ma Y; Duan L; Li L; Lu W; Li B; Chen X
J Gastrointest Oncol; 2021 Apr; 12(2):762-769. PubMed ID: 34012664
[TBL] [Abstract][Full Text] [Related]
12. Argon-helium cryoablation for thoracic vertebrae with metastasis of hepatocellular carcinoma-related hepatitis B: A case report.
Tan YW; Ye Y; Sun L
World J Clin Cases; 2020 Jan; 8(2):377-381. PubMed ID: 32047788
[TBL] [Abstract][Full Text] [Related]
13. Predictors of intermediate-term survival with destination locoregional therapy of hepatocellular cancer in patients either ineligible or unwilling for liver transplantation.
Ramanathan M; Shroads M; Choi M; Wood D; Seetharam A
J Gastrointest Oncol; 2017 Oct; 8(5):885-889. PubMed ID: 29184693
[TBL] [Abstract][Full Text] [Related]
14. Alcoholization of pyogenichepatic abscess with absolute alcohol in Bama minipigs.
Zhang RG; Zhang XL; Yang YS
Exp Ther Med; 2017 Nov; 14(5):4483-4488. PubMed ID: 29067123
[TBL] [Abstract][Full Text] [Related]
15. Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.
Eun HS; Lee BS; Kwon IS; Yun GY; Lee ES; Joo JS; Sung JK; Moon HS; Kang SH; Kim JS; Shin HJ; Kim TK; Chun K; Kim SH
Dig Dis Sci; 2017 Sep; 62(9):2586-2600. PubMed ID: 28744835
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy.
Miranda D; Carter K; Luo D; Shao S; Geng J; Li C; Chitgupi U; Turowski SG; Li N; Atilla-Gokcumen GE; Spernyak JA; Lovell JF
Adv Healthc Mater; 2017 Aug; 6(16):. PubMed ID: 28504409
[TBL] [Abstract][Full Text] [Related]
17. Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients.
Wu LL; Hsieh MC; Chow JM; Liu SH; Chang CL; Wu SY
Medicine (Baltimore); 2016 Sep; 95(36):e4639. PubMed ID: 27603355
[TBL] [Abstract][Full Text] [Related]
18. Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development.
Tu T; Budzinska MA; Maczurek AE; Cheng R; Di Bartolomeo A; Warner FJ; McCaughan GW; McLennan SV; Shackel NA
Int J Mol Sci; 2014 May; 15(6):9422-58. PubMed ID: 24871369
[TBL] [Abstract][Full Text] [Related]
19. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma.
Zheng SG; Xu HX; Lu MD; Xie XY; Xu ZF; Liu GJ; Liu LN
World J Gastroenterol; 2013 Feb; 19(6):855-65. PubMed ID: 23430451
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
